関連する実験動画
CXCR4ケモカインGPCRの構造は,小分子および周期性ペプチドアンタゴニストによるものです
Beili Wu1, Ellen Y T Chien, Clifford D Mol
1Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
まとめ
ケモカイン受容体CXCR4の構造的な洞察は,細胞移動に不可欠なホモジマーを示しています. これらの発見は,癌の転移とHIV-1感染の理解に影響を与えます.
科学分野:
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
背景:
- CXCR4のようなケモカイン受容体は,免疫細胞の移動を調節する.
- CXCR4は癌の転移とHIV-1感染に関与している.
研究 の 目的:
- 抗体と結合するCXCR4の結晶構造を決定する.
- CXCR4機能とリガンド相互作用の構造的基礎を解明する.
主な方法:
- X線結晶グラフィーです.
- 2.5から3.2アンストームの解像度で構造を決定する.
- CXCR4-リガンド複合体の分析.
主要な成果:
- 抗体IT1tとCVX15とのCXCR4の5つの結晶構造が決定されました.
- ヘリックスVとVIを含む一貫したホモジマーインターフェースが観察されました.
- CXCR4のリガンド結合部位は,他のGPCRと区別され,細胞外表面の近くに位置しています.
結論:
- 特定されたCXCR4ホモディマーは,受容体シグナル伝達を調節する可能性があります.
- 構造データは,CXCR4とCXCL12およびHIV-1 gp120との相互作用に関する洞察を提供します.
- これらの発見は,CXCR4を標的とした新しい治療法を開発するための基礎を提供します.
関連する概念動画
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Transducer Mechanism: G Protein–Coupled Receptors
3.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.9K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K